Heyman Richard A.

Heyman Richard A. is listed in filings as Director at Enliven Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 19, 2026, including sale activity. Recent filings connect the profile to Enliven Therapeutics, Inc. (ELVN), ORIC Pharmaceuticals, Inc. (ORIC), and PMV Pharmaceuticals, Inc. (PMVP). The current snapshot covers public activity from Jun 14, 2024 to Feb 19, 2026. Reported amounts are shown as $32.2K to $19.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.